物质信息
ID:449181
名称和标识
IUPAC标准名
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl benzoate
别名
YewtaxanAnzataxPaclitaxelTaxol A
IUPAC传统名
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl benzoate
数据登录号
CAS号
化合物性质
产品相关信息
应用领域
Antileukaemic and antineoplastic agent, esp. against melanoma and ovarian tumours
Use limited by low solubility and scarce availability of Taxus brevifolia bark
Biochemical tool extensively used to study cellular shape and function.
Also shown to be active against oomycete fungi
生物来源
Isol. from the stem bark of Taxus brevifolia and Taxus cuspidata (Taxaceae)
药理学性质
生物活性机理
Interferes with the normal function of microtubule growth by hyper-stabilisation of their structure
Binds to the beta subunit of tubulin
描述信息
暂无数据
点击上传数据
分子图谱
暂无数据
点击上传数据
参考文献
• Kingston, D.G.I. et al., J. Nat. Prod., 1982, 45, 466-470, (2',7-di-Ac)
• Horwitz, S.B. et al., Ann. N.Y. Acad. Sci., 1986, 466, 733, (rev, pharmacol)
• Kingston, D.G.I., Pharmacol. Ther., 1991, 52, 1, (rev, pharmacol)
• Joel, S.P., Chem. Ind. (London), 1994, 172, (rev)
• Kingston, D.G.I. et al., J. Nat. Prod., 1990, 53, 1; 802, (bibl, rev)
• Williams, H.J. et al., Tetrahedron, 1993, 49, 6545, (pmr, conformn)
• Suffness, M. et al., Alkaloids (N.Y.), 1985, 25, 10, (rev, pharmacol)
• Slichenmyer, W.J. et al., Anti-Cancer Drugs, 1991, 2, 519, (rev)
• Fleming, P.E. et al., J.A.C.S., 1993, 115, 805, (biosynth)
• Young, D.H. et al., Experientia, 1992, 48, 882, (antifungal activity)
• Horwitz, S.B., Trends Pharmacol. Sci., 1992, 13, 134, (rev)
• Wall, M.E., Chron. Drug Discovery, 1993, 3, 327, (rev)
• Hoke, S.H. et al., J. Nat. Prod., 1994, 57, 277, (ms)
• Wani, M.S. et al., J.A.C.S., 1971, 93, 2325, (isol, nmr, ms, ir, uv)
• Falzone, C.J. et al., Tet. Lett., 1992, 33, 1169, (pmr, cmr)
• Ojima, I. et al., Tetrahedron, 1992, 48, 6985, (synth)
• Wheeler, N.C. et al., J. Nat. Prod., 1992, 55, 432, (occur)
• Hilton, B.D. et al., J. Nat. Prod., 1992, 55, 1157, (pmr)
• Stierle, A. et al., Science (Washington, D.C.), 1993, 260, 214, (isol, ms)
• Rose, W.C., Anti-Cancer Drugs, 1992, 3, 311, (rev)
• Winkler, J.D. et al., Tetrahedron, 1992, 48, 6953, (rev)
• Nicolaou, K.C. et al., Angew. Chem., Int. Ed., 1994, 33, 15, (rev)
• Huang, C.H.O. et al., J. Nat. Prod., 1986, 49, 665, (isol, deriv)
• Blechert, S. et al., Alkaloids (N.Y.), 1990, 39, 195, (rev, pharmacol)
• Potier, P., Chem. Soc. Rev., 1992, 21, 113, (rev)
• Chmurny, G.N. et al., J. Nat. Prod., 1992, 55, 414, (pmr, cmr)
• Zhang, H. et al., Yunnan Zhiwu Yanjiu, 1993, 15, 424; CA, 121, 78282e
• Sonnichsen, D.S. et al., Clin. Pharmacokinet., 1994, 27, 256, (rev, pharmacokinet)
• Hongjie, Z. et al., Heterocycles, 1994, 38, 975
• Gimon, M.E. et al., J. Nat. Prod., 1994, 57, 1404, (ms)
• Nicolaou, K.C. et al., Nature (London), 1994, 367, 630, (synth)
• Nicolaou, K.C. et al., J.A.C.S., 1995, 117, 624; 634; 645; 653, (synth)
• Taxol: Science and Applications, Ed., Suffness, M, CRC Press, Boca Raton, USA, 1995, (book)
• Shiina, I. et al., Chem. Lett., 1998, 3-4, (synth)
• Mukaiyama, T. et al., Chem. Eur. J., 1999, 5, 121-161, (Taxol, synth, rev)
• Martindale, The Extra Pharmacopoeia, 32nd edn., Pharmaceutical Press, 1999, 556
• Kerns, E.H. et al., J. Nat. Prod., 1994, 57, 1391, (ms)
• Fleming, P.E. et al., Pure Appl. Chem., 1994, 66, 2045, (biosynth)
• Kingston, D.G.I. et al., Tet. Lett., 1994, 35, 4483, (synth)
• Nogales, E. et al., Nature (London), 1995, 375, 424
• Danishefsky, S.J. et al., J.A.C.S., 1996, 118, 2843, (synth)
• Heinstein, P. et al., J.C.S. Perkin 1, 1996, 845, (ms)
• Gao, Q. et al., Acta Cryst. C, 1995, 51, 295, (cryst struct)
• Rowinsky, E.K. et al., N. Engl. J. Med., 1995, 332, 1004, (use, tox, rev)
• Wender, P.A. et al., J.A.C.S., 1997, 119, 2757, (synth)
• Gennari, C. et al., J.O.C., 1997, 62, 4746-4755, (synth)
• Kusama, H. et al., J.A.C.S., 2000, 122, 3811-3820, (synth)
• Huizing, M.T. et al., J. Chromatogr., B: Biomed. Appl., 1995, 664, 373, (hplc)
• Baloglu, E. et al., J. Nat. Prod., 1999, 62, 1068-1071, (synth)
• Vyas, D.M. et al., Prog. Med. Chem., 1995, 32, 289, (rev)
• Nicolaou, K.C. et al., Classics in Total Synthesis, Targets, Strategies, Methods, VCH, 1996, 655, (bibl, synth)
• Walker, K. et al., Phytochemistry, 2001, 58, 1-7, (biosynth, rev)
• The Chemistry and Pharmacology of Taxol(R) and its Derivatives, (Ed. Farina, V.), Elsevier, 1995, (book)
• Gao, Q. et al., Tetrahedron, 1996, 52, 2291, (cryst struct)
• Eisenhauer, E.A. et al., Drugs, 1998, 55, 5-30, (pharmacol, rev)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, TAH775
• Holton, R.A. et al., J.A.C.S., 1994, 116, 1597; 1599, (synth)
• Fleming, P.E. et al., J.A.C.S., 1994, 116, 4137, (biosynth)
• Georg, G.I. et al., ACS Symp. Ser., 1995, 583, (book)
• Grothaus, P.G. et al., J. Nat. Prod., 1995, 58, 1003, (immunoassay)
• Rao, K.V., J. Het. Chem., 1997, 34, 675-680, (synth)
• Hezari, M. et al., Planta Med., 1997, 63, 291-295, (biosynth, rev)
• Ranson, M. et al., Expert Opin. Invest. Drugs, 1999, 8, 837-848
• Das, B. et al., Indian J. Chem., Sect. B, 1999, 38, 1018-1024, (rev)